|
ID | Description | value | Adjust value | Gene number |
|
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.2722E − 31 | 8.83495E − 29 | 34 |
hsa05418 | Fluid shear stress and atherosclerosis | 8.02758E − 26 | 6.42442E − 24 | 34 |
hsa04657 | IL-17 signaling pathway | 2.23263E − 21 | 6.69789E − 20 | 26 |
hsa04668 | TNF signaling pathway | 1.93321E − 20 | 5.21968E − 19 | 27 |
hsa04659 | Th17 cell differentiation | 1.77974E − 17 | 3.00331E − 16 | 24 |
hsa04210 | Apoptosis | 5.07009E − 17 | 8.0525E − 16 | 26 |
hsa04218 | Cellular senescence | 1.70327E − 15 | 1.9995E − 14 | 26 |
hsa04066 | HIF-1 signaling pathway | 4.55414E − 15 | 4.72929E − 14 | 22 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.19998E − 14 | 1.11722E − 13 | 19 |
hsa04115 | p53 signaling pathway | 3.86218E − 14 | 3.36383E − 13 | 18 |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.25365E − 13 | 9.95542E − 13 | 19 |
hsa04380 | Osteoclast differentiation | 1.52063E − 13 | 1.14047E − 12 | 22 |
hsa04620 | Toll-like receptor signaling pathway | 2.26415E − 13 | 1.5283E − 12 | 20 |
hsa04660 | T Cell receptor signaling pathway | 2.26415E − 13 | 1.5283E − 12 | 20 |
hsa04012 | ErbB signaling pathway | 6.6254E − 13 | 4.25919E − 12 | 18 |
hsa04151 | PI3K-akt signaling pathway | 1.24292E − 12 | 7.80436E − 12 | 34 |
hsa04370 | VEGF signaling pathway | 3.47037E − 12 | 1.99361E − 11 | 15 |
hsa04915 | Estrogen signaling pathway | 6.54943E − 12 | 3.60403E − 11 | 21 |
hsa04010 | MAPK signaling pathway | 6.67413E − 12 | 3.60403E − 11 | 30 |
hsa04658 | Th1 and Th2 cell differentiation | 3.05E − 11 | 1.55E − 10 | 17 |
hsa04068 | FoxO signaling pathway | 1.6511E − 10 | 7.96064E − 10 | 19 |
hsa04064 | NF-kappa B signaling pathway | 2.32207E − 10 | 1.09993E − 09 | 17 |
hsa04621 | NOD-like receptor signaling pathway | 1.2042E − 09 | 5.16086E − 09 | 21 |
hsa04931 | Insulin resistance | 3.58386E − 09 | 1.423E − 08 | 16 |
hsa04662 | B Cell receptor signaling pathway | 5.33879E − 09 | 2.08909E − 08 | 14 |
hsa04024 | cAMP signaling pathway | 5.66891E − 09 | 2.1641E − 08 | 22 |
hsa04910 | Insulin signaling pathway | 1.80579E − 08 | 6.58868E − 08 | 17 |
hsa04912 | GnRH signaling pathway | 2.87106E − 08 | 1.03358E − 07 | 14 |
hsa04071 | Sphingolipid signaling pathway | 1.04592E − 07 | 3.62048E − 07 | 15 |
hsa04014 | Ras signaling pathway | 4.64353E − 07 | 1.475E − 06 | 20 |
hsa04920 | Adipocytokine signaling pathway | 5.07934E − 07 | 1.57635E − 06 | 11 |
hsa04062 | Chemokine signaling pathway | 5.25301E − 07 | 1.61172E − 06 | 18 |
hsa04110 | Cell cycle | 1.11163E − 06 | 3.15936E − 06 | 14 |
hsa04630 | JAK-STAT signaling pathway | 1.15731E − 06 | 3.25493E − 06 | 16 |
hsa00140 | Steroid hormone biosynthesis | 1.30408E − 06 | 3.59286E − 06 | 10 |
hsa04930 | Type II diabetes mellitus | 9.82492E − 06 | 2.50258E − 05 | 8 |
hsa05323 | Rheumatoid arthritis | 1.03843E − 05 | 2.62033E − 05 | 11 |
hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.6295E − 05 | 8.67227E − 05 | 11 |
hsa03320 | PPAR signaling pathway | 6.67976E − 05 | 0.000155477 | 9 |
hsa04020 | Calcium signaling pathway | 7.36869E − 05 | 0.000168606 | 15 |
hsa04310 | Wnt signaling pathway | 9.54755E − 05 | 0.000213045 | 13 |
hsa04929 | GnRH secretion | 0.000116074 | 0.000254797 | 8 |
hsa04022 | cGMP-PKG signaling pathway | 0.000147423 | 0.000321001 | 13 |
hsa04015 | Rap1 signaling pathway | 0.00041579 | 0.000863564 | 14 |
hsa04666 | Fc gamma R-mediated phagocytosis | 0.00195976 | 0.003834313 | 8 |
hsa04152 | AMPK signaling pathway | 0.002019554 | 0.003922874 | 9 |
hsa01212 | Fatty acid metabolism | 0.002098286 | 0.003989699 | 6 |
hsa04923 | Regulation of lipolysis in adipocytes | 0.002098286 | 0.003989699 | 6 |
hsa04150 | mTOR signaling pathway | 0.010773083 | 0.018409699 | 9 |
hsa04918 | Thyroid hormone synthesis | 0.031361971 | 0.049810189 | 5 |
|